METHODS ELABORATION ON DETECTION OF SOME ATYPICAL NEUROLYTIC AGENTS FOR CHEMICAL AND TOXICOLOGICAL ANALYSIS


Cite item

Abstract

It is necessary to elaborate methods of atypical neuroleptic agents detection as individual substances and in different combinations as well for diagnosis of poisoning by some of them: clozapine, risperidone, sertindole, olanzapine, aripiprazole. The purpose of this work is methods elaboration of detection of clozapine, risperidone, sertindole, olanzapine, aripiprazole, haloperidol, oxazepam, carbamazapine using TLC, HPLC and UV spectrophotometry methods.During this work we used tablet forms of clozapine, risperidone, sertindole, olanzapine, aripiprazole. It is possible to use solution systems like ethanol-water-25% ammonia solution (8:1:1), toluol-acetone-ethanol-25% ammonia solution (45:45:7.5:2.5), dioxan-chloroform-acetone-25% ammonia solution (47.5:45:5:2.5) for preliminary examination of atypical neuroleptic agents under study in combination with typical neuroleptics and tranquilizers with undirected analysis (general screening). System of solvents ethyl-acetate-chloroform-25% ammonia solution (85:10:5) is recommended to use for individual screening of risperidone, sertindole, olanzapine, haloperidol, benzol-ethanol-25% ammonia solution (50:10:0.5) system to use for clozapine, sertindole, olanzapine. Ethanol-25% ammonia solution (100:1.5) system is reasonable to use for chromatographic clearance of extracts from biological substances under study. We recommend using HPLC method and UV spectrophotometry for carrying out of a principal examination of clozapine, risperidone, sertindole, olanzapine and aripiprazole in case one of the substances under study is determined in the object.

About the authors

I. P Remezova

Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk

Email: i.p.remezova@pmedpharm.ru

D. S Lazaryan

Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk

Email: j.s.lazaryan@pmedpharm.ru

T. I Maksimenko

Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk

D. Yu Sanzhieva

Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk

A. Yu Rybasova

Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk

References

  1. Маляров С.А. Чем должен руководствоваться врач при назначении комбинированной антипсихотической терапии? [Электронный ресурс]. - Режим доступа: http://www.health-ua.org/archives/health/738.html.
  2. Поспелова, А.А. Оценка возможности использования обращенно-фазной тонкослойной хроматографии в химико-токсикологических исследованиях ряда групп лекарственных и химических соединениях / А.А. Поспелова, Л.Н. Карпова, Т.Л. Малкова // Токсикологический вестник. - 2012. - №2.
  3. Livingstone M.G. Management of schizophrenia // Prescribers J. - 1996. - № 36. - Р. 206-215.
  4. The use of atypical antipsychotics in the management of schizophrenia / M. Cambell [et al] // British Journal of Clinical Pharmacology. - 2000. - №6. - P. 432-438.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Remezova I.P., Lazaryan D.S., Maksimenko T.I., Sanzhieva D.Y., Rybasova A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).